Lerodalcibep: Another Crucial Addition to the Dyslipidaemia Arsenal

dc.authorid0000-0003-0312-9910
dc.contributor.authorSahebkar, Amirhossein
dc.contributor.authorKarav, Sercan
dc.contributor.authorAlmahmeed, Wael
dc.contributor.authorJamialahmadi, Tannaz
dc.date.accessioned2026-02-03T12:00:07Z
dc.date.available2026-02-03T12:00:07Z
dc.date.issued2025
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description.abstract[No abstract available]
dc.identifier.doi10.31083/RCM42070
dc.identifier.issn1530-6550
dc.identifier.issn2153-8174
dc.identifier.issue9
dc.identifier.pmid41089781
dc.identifier.scopus2-s2.0-105020769023
dc.identifier.scopusqualityQ3
dc.identifier.urihttps://doi.org/10.31083/RCM42070
dc.identifier.urihttps://hdl.handle.net/20.500.12428/34522
dc.identifier.volume26
dc.identifier.wosWOS:001592020900002
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherImr Press
dc.relation.ispartofReviews in Cardiovascular Medicine
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20260130
dc.titleLerodalcibep: Another Crucial Addition to the Dyslipidaemia Arsenal
dc.typeLetter

Dosyalar